Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Charles L Daley

Showing results (81-90 of 230) with videos related to

Pageof 23
Sort By:
Annals of the American Thoracic Society|November 6, 2015
Improvement in Quality of Life after Therapy for Mycobacterium abscessus Group Lung Infection. A Prospective Cohort StudyChristopher A Czaja, Adrah R Levin, Christian W Cox, et al.
Chest|June 15, 2016
Lung Function Decline According to Clinical Course in Nontuberculous Mycobacterial Lung DiseaseHye Yun Park, Byeong-Ho Jeong, Hae Ri Chon, et al.
Chest|May 10, 2017
Safety and Effectiveness of Clofazimine for Primary and Refractory Nontuberculous Mycobacterial InfectionStacey L Martiniano, Brandie D Wagner, Adrah Levin, et al.
Antimicrobial Agents and Chemotherapy|April 1, 2024
<i>In vitro</i> activity of cefoxitin, imipenem, meropenem, and ceftaroline in combination with vaborbactam against <i>Mycobacterium abscessus</i>Liang Chen, Elena Shashkina, Natalia Kurepina, et al.
The Clinical Respiratory Journal|May 7, 2014
Non-tuberculous mycobacterial infections at San Francisco General HospitalLeslie C Sheu, Tu M Tran, Leah G Jarlsberg, et al.
American Journal of Respiratory and Critical Care Medicine|June 9, 2004
Tuberculosis treatment outcomes: directly observed therapy compared with self-administered therapyRobert M Jasmer, Christopher B Seaman, Leah C Gonzalez, et al.
Clinical Immunology (Orlando, Fla.)|November 23, 2007
IL-9 is associated with an impaired Th1 immune response in patients with tuberculosisBo Wu, Chunhong Huang, Midori Kato-Maeda, et al.
Antimicrobial Agents and Chemotherapy|October 3, 2012
In vitro synergy between clofazimine and amikacin in treatment of nontuberculous mycobacterial diseaseJakko van Ingen, Sarah E Totten, Niels K Helstrom, et al.
The Journal of Antimicrobial Chemotherapy|December 31, 2024
In vitro susceptibility of 147 international clinical Mycobacterium abscessus isolates to epetraborole and comparators by broth microdilutionMinh-Vu H Nguyen, Vinicius Calado Nogueira de Moura, Tiffany R Keepers, et al.
Chest|February 12, 2005
Hypersensitivity pneumonitis reaction to Mycobacterium avium in household waterTheodore K Marras, Richard J Wallace, Laura L Koth, et al.
Pageof 23

Showing results (81-90 of 230) with videos related to

Sort By:
Pageof 23
Annals of the American Thoracic Society|November 6, 2015
Improvement in Quality of Life after Therapy for Mycobacterium abscessus Group Lung Infection. A Prospective Cohort StudyChristopher A Czaja, Adrah R Levin, Christian W Cox, et al.
Chest|June 15, 2016
Lung Function Decline According to Clinical Course in Nontuberculous Mycobacterial Lung DiseaseHye Yun Park, Byeong-Ho Jeong, Hae Ri Chon, et al.
Chest|May 10, 2017
Safety and Effectiveness of Clofazimine for Primary and Refractory Nontuberculous Mycobacterial InfectionStacey L Martiniano, Brandie D Wagner, Adrah Levin, et al.
Antimicrobial Agents and Chemotherapy|April 1, 2024
<i>In vitro</i> activity of cefoxitin, imipenem, meropenem, and ceftaroline in combination with vaborbactam against <i>Mycobacterium abscessus</i>Liang Chen, Elena Shashkina, Natalia Kurepina, et al.
The Clinical Respiratory Journal|May 7, 2014
Non-tuberculous mycobacterial infections at San Francisco General HospitalLeslie C Sheu, Tu M Tran, Leah G Jarlsberg, et al.
American Journal of Respiratory and Critical Care Medicine|June 9, 2004
Tuberculosis treatment outcomes: directly observed therapy compared with self-administered therapyRobert M Jasmer, Christopher B Seaman, Leah C Gonzalez, et al.
Clinical Immunology (Orlando, Fla.)|November 23, 2007
IL-9 is associated with an impaired Th1 immune response in patients with tuberculosisBo Wu, Chunhong Huang, Midori Kato-Maeda, et al.
Antimicrobial Agents and Chemotherapy|October 3, 2012
In vitro synergy between clofazimine and amikacin in treatment of nontuberculous mycobacterial diseaseJakko van Ingen, Sarah E Totten, Niels K Helstrom, et al.
The Journal of Antimicrobial Chemotherapy|December 31, 2024
In vitro susceptibility of 147 international clinical Mycobacterium abscessus isolates to epetraborole and comparators by broth microdilutionMinh-Vu H Nguyen, Vinicius Calado Nogueira de Moura, Tiffany R Keepers, et al.
Chest|February 12, 2005
Hypersensitivity pneumonitis reaction to Mycobacterium avium in household waterTheodore K Marras, Richard J Wallace, Laura L Koth, et al.
Pageof 23